Immunoproliferative small intestinal disease (IPSID) A model for mature B-cell neoplasms -Review Introduction
Malignant lymphomas of the small intestine are relatively common in certain geographic areas and they seem to be particularly so in developing countries, especially in the Middle East and North Africa. 1 In the Iraqi tumor registry (1986) (1987) (1988) , for example, small intestinal lymphoma constituted about 19% of all non-Hodgkin lymphomas and 78% of all small intestinal malignant tumors. Generally, these lymphomas can be divided into three subtypes. 2 Burkitt lymphoma, which is most common in children, usually involves the terminal ileum with extensive abdominal involvement. The second, relatively uncommon, is similar to the "Western" type of nonHodgkin lymphomas most commonly large B-cell type involving various parts of the small intestine. The third type is the so-called Mediterranean lymphoma affecting mainly young adults with almost equal sex incidence and involves predominantly the proximal small intestine and is usually associated with chronic diarrhea and abdominal pain. 3 In
1978, the World Health Organization recommended the term "Immunoproliferative Small
Intestinal Disease (IPSID)" for the syndrome associated with Mediterranean lymphoma because at that time it was felt that the disease in its early stages "does not appear to be truly malignant lymphoma". 4 Many of the patients with IPSID syndrome were found to have variable levels of abnormal immunoglobulin in the serum or other body fluids, which was later identified to be truncated heavy chains ( HC). 5 Generally, at the present time IPSID is considered as a variant of mucosa associated lymphoid tissue (MALT) lymphoma. 6 In the recent
For personal use only. on August 16, 2017 . by guest www.bloodjournal.org From WHO classification of hemopoietic and lymphoid tissue IPSID is listed with the heavy chain diseases as a special variant of extranodal marginal zone B-cell (MALT) lymphoma. 7 However, the WHO classification does not recognize the so-called "nonsecretory" IPSID as a specific entity. This variant, similar to MALT lymphomas of other mucosal sites is characterized morphologically by the proliferation of small centrocytelike lymphoid cells lacking the extreme plasmacytic differentiation observed in HC secretory form. Both "secretory" and "non-secretory" forms are common in the same geographic area, but have different local geographic distribution. 8 For the purpose of this review, the terms IPSID and heavy chain disease ( HCD) are used synonymously to refer to the secretory form, a relatively well defined clinicopathologic entity. This is not withstanding the fact that there are rare patients with rather than heavy chain IPSID 9 and the rare colonic, gastric or pulmonary HCD. [10] [11] [12] IPSID is a unique mature B-cell neoplasm regarding its epidemiology, clinical features, morphology and molecular pathogenesis. 13 It shares certain features with gastrointestinal MALT lymphomas, lymphoplasmacytic lymphoma as well as plasma cell neoplasms. Though rare in many parts of the world, clinical experience and molecular investigation over the period of four decades has contributed not only to the diagnosis and management of IPSID, but also to the understanding of the pathogenesis and evolution of these B-cell neoplasms.
Epidemiology and clinical features
IPSID affects mainly older children and young adults (10-35 years old, mean [25] [26] [27] [28] [29] [30] , of low socioeconomic status in developing countries. It is uncommon in young children and older adults. Geographically, the majority of cases reported were from the Middle East, North and South Africa, and the Far East. [14] [15] [16] [17] [18] Sporadic cases have been upper jejunum in all patients except very early in the disease. Thickening, erythema and nodularity of the mucosal folds are noted. 16, 17 As the disease progresses, tumors appear usually in the proximal small intestine and rarely in the stomach.
Pathology and Evolution:
The main pathological feature of IPSID is the presence of dense mucosal infiltrate of "centrocyte-like" and many plasma cells involving long segments of the small bowel mucosa, predominantly the proximal parts. 2, 14 The overlying epithelial cells are usually intact, and the crypts are sparse. (Fig 1, C&D 31 32 These stains demonstrate positivity for HC, while the light chain stains are negative.
HCD proteins are almost always 1 species and appear to consist largely of multiple polymers of different sizes.
14 The molecular weight of the basic monomeric unit varies between 29,000 and 35,000. Allowance is usually made in these figures for carbohydrate, since the carbohydrate content of many of these HCD proteins is unusually high. Thus, the length of the basic polypeptide subunit varies from patient to patient and in most instances it is between half and three-fourths the size of its normal counterpart. 33 Sequenced data showed that the HCD protein lacked the V H and the first constant domain. Normal sequence resumed at the beginning of the hinge region, with a valine residue corresponding to position 222 of a normal 1 chain. The carboxy terminal structure and conformational integrity remain intact. 33, 34 The HCD protein has various deletions, insertions, and mutations similar to those observed in the much less common and µ heavy chain diseases.
(Fig 2)
As expected, the HCD messengerRNA lacks the V H and C H 1 sequences. It also contains an in-frame insert of unknown origin between the leader peptide and the normal C H 2 and C H 3 coding sequences. 34, 35 These inserts are of variable length (42 to 105bp) and they are unrelated to each other. Their structure suggests that they result from alternative splicing process. These sequences do not resemble any normal human genomic DNA. The absence of homology between these insertions could not support the hypothesis of infectious non-human DNA, either. They may represent highly altered sequences from human Ig locus. Since the amino acid sequence of HCD proteins
For personal use only. on August 16, 2017 . by guest www.bloodjournal.org From begins with a C H 2 domain, it is most likely that the amino acid terminal sequence encoded by these insertions is cleaved intracellularly before secretion. 36 The complete gene sequence encoding three HCD proteins, MAL, 35 YAO 37 and SEC has been determined. 38 These three genes show a striking similarity in their position and extent of the two main deletions, which encompass sequences in the V/J and the switch/C H 1 regions. In all cases, most, or all of the V region is deleted as is the sequence starting in the switch region and extending through part, or all of the C H 1 domain.
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These findings are also similar to those present in the two heavy chain proteins gene sequenced (OMN 40 and RIV 41 ). Taken together the analysis of and HCD proteins and nucleic acids seem to show the emerging pattern of two large non-contiguous deletions in the heavy chain genes and the expression of low levels of light chain constant regions. 40 Analysis of the DNA from IPSID tumors showed monoclonal heavy and light chain gene rearrangement even in the early stages of the disease. 42 Southern blot analysis established that in all cases one or both genes were rearranged in tumor DNA, whereas the genes were in germ-line configuration. In some cases, the truncated mRNA were shorter than a normal kappa mRNA. This finding was interpreted as indicating the occurrence of genomic alterations in both heavy and light chain loci in HCD, as demonstrated by the analysis of the sequence of rearranged gene in a case of HCD. 43 As a characteristic of and HCD there are no light chains detected in the serum or associated with the heavy chain fragments in most cases. Studies reported from various laboratories suggested that independent structural gene abnormalities are at least partially responsible for the uniform absence of detectable light chain production in HCD. In contrast to most normal and neoplastic Ig-producing cells, there is excess of heavy to 44 In all cases studied, the HCD protein was found in the jejunal juice when it was already present in the serum. HC protein was found in the intestinal or gastric lumen in some cases, although it was undetectable in the sera of these patients in spite of the use of the most sensitive technique. 14 The concentration of HCD protein in urine is low and BenceJones proteinuria has never been found. It was also noted that in rare cases the HCD protein is absent from the serum, urine and jejunal juice, but can be demonstrated by immunohistochemical staining of small bowel biopsies 31 or that the Ig gene is rearranged by molecular studies. 45 It was demonstrated that gene deletions force "non-secretory"
HCD plasma cells to produce membrane form chain only. 38 In the vast majority of IgA is dimeric or tetrameric. It contains joining (J) chains that help recognize the receptor (pIgR) expressed on basolateral surfaces of adjacent epithelial cells. 46 Light chains have been shown to play a critical role in the Ig molecule secretions by the plasma cells. 47 In HCD mutations in the both heavy and the light chains seem to result in the secretions of the truncated heavy chains by the neoplastic plasma cells in spite of the absence of light chains. J-chains are present in the majority of HCD proteins. 16 However, the production of these truncated HCD proteins probably outpace the synthesis of the secretory component by the enterocytes. This could be expected because in IPSID the crypts are atrophic and highly dispersed in contrast to celiac disease where they are hyperplastic. (Fig 1, C,D) Thus, large amounts of polymeric HCD protein can usually be demonstrated in the serum and also in the jejunal and gastric fluids.
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Cytogenetics of IPSID:
Although considered as a variant of MALT lymphoma, IPSID lacks the (11;18) chromosome translocation demonstrated in relatively high frequency in other MALT lymphomas, particularly those of the lung, stomach, conjunctiva and orbit. 48 However,
other clonal cytogenetic abnormalities were demonstrated in the IPSID lymphoid cells of mesenteric lymph nodes, even in patients with early stage disease limited to the mucosa.
In one patient, rearrangement resulted from translocation (9;14) in 21 out of 23 mitoses.
The rearranged 1 gene fragment in that case was cloned and it was shown to contain 25 It is interesting also to note that the AML1 gene may be involved in some cases of multiple myeloma.
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Taken together, the relatively few cytogenetic studies in IPSID demonstrate clonal abnormalities involving the p32 heavy chain locus on chromosome 14 as well as the light chain loci on chromosomes 2 and 22, sharing features with both malignant lymphoma and immunoproliferative diseases.
Pathogenesis
The search for pathogenic factors was related to the well-known unique features of IPSID i.e. its ethnic and geographic distribution as well its response to antibiotics, at least in the early stages. A striking association of IPSID with human leukocyte antigens (HLA), AW19, A9 and B12 and the B blood group has been described. 52, 53 Genetic predisposition is further substantiated by the development of IPSID in relatives living apart 53 and the presence of elevated intestinal isoenzyme alkaline phosphatase, a feature However, this association has been challenged. C. jejuni is an initiating factor in chronic autoimmune disease such as Guillan-Barre Syndrome and reactive arthritis. It is not known to be a persistent colonizer of human gut, 13 except in immunodeficient individuals. 54 Besides, the temporal relation between C. jejuni and IPSID is unknown. 54 We believe that the association with C. jejuni can fit into a plausible working hypothesis for the pathogenesis of IPSID. (Fig 1 57 We have previously hypothesized that these immunologic immune defects may be attributed to the modulatory effects of V. cholerae toxins acquired during the epidemic that swept the same IPSID geographic areas during the early sixties. 55 It is interesting to note that the reports on IPSID started to appear in these areas a few years after the Eltor cholera epidemic.
One can speculate too, that in the presence of continuous antigenic stimulation within the gut and due to a presumed C. jejuni infection, IgA producing plasma cells proliferate in the lamina propria of the small intestine. (Fig 1) Deletions and insertions develop at a high rate (approximately 6%) of somatic mutation introduced into rearranged V H region genes during normal development of germinal center B-cells. 58 Besides C.
jejuni cytolethal distending toxin is known to induce double-stranded-DNA breaks. Treatment and Outcome (Table 3) For personal use only. on August 16, 2017 . by guest www.bloodjournal.org From Although spontaneous remissions occur in early stages, once established the untreated disease progresses relentlessly causing severe malabsorption and malnutrition.
Early treatment is recommended to control the symptoms and hopefully slow, or prevent progression of the disease. 60 The Tunisian/French group published a small prospective study of twenty-one Tunisian patients with IPSID all of whom underwent laparotomy and elaborate staging and investigative procedures. 28 Six had early disease confined to the small bowel wall, thirteen had advanced disease with tumor formation and two were 
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within twelve months should be given CHOP (cyclophosphamide vincristine adriamycin and prednisone) chemotherapy. Chemotherapy was also recommended upfront together with antibiotics for patients with advanced disease at presentation. The average overall CR rate using this regimen was around 50% and the median survival was 67% at three years. This regimen also agrees with the clinical trials where anthracycline containing regimen was found to be superior to non-anthracycline regimen. 62 Relapses of the low grade IPSID component may happen as expected and may be controlled by antibiotics alone. 63 Whether maintenance antibiotic is necessary for a long period of time is not established. Life long suppression of antigenic stimulus has been proposed. 64 Response 14 but to our knowledge there are no reports in the literature demonstrating the utility of bone marrow or hematopoietic cell transplant in IPSID.
Future Investigations:
We believe that the more recent discoveries in the molecular pathogenesis of IPSID raise some important questions that can be answered only by cooperative international studies. The real incidence and the geographic distribution of IPSID needs to be better defined. Studies from the Middle East indicate a decline in the incidence of IPSID over the last three decades, 65-67 a phenomenon which could not be totally explained by improved socioeconomic and hygienic conditions. International cancer registry comparative studies are needed to document this decline, and an attempt be made to explain it. The role of C. jejuni and maybe other bacterial organisms including V.
cholerae needs more clinicopathologic and experimental studies. The contribution of double-strand-DNA breaks caused by C. jejuni toxin to carcinogenesis is an important topic for future studies, since that organism is relatively prevalent all over the world.
The frequent occurrence of deletions and duplications during somatic hypermutations occurring normally in the germinal center B-cells has been implicated for oncogene translocations in Burkitt lymphoma as well as HCD. 58 Abdominal and intestinal Burkitt lymphomas are relatively common childhood tumors in the same geographic areas as IPSID. Malaria was eradicated in these areas for many years thus the high frequency of Burkitt lymphoma cannot be blamed on endemic malaria as in Africa. 68 More than two decades ago, we envisioned a common pathway for the pathogenesis of these two types of lymphoma with Burkitt lymphoma developing due to an EBV infection in children previously not exposed to EBV and IPSID developing due to
For personal use only. on August 16, 2017 . by guest www.bloodjournal.org From another presumed infection in young adults immune to EBV. (Fig 1) We speculate that chronic C. jejuni infection can explain the high incidence of IPSID in young adults versus Burkitt lymphoma, which is EBV related in children. However, more studies are needed to clarify the mechanism(s) involved in IPSID and intestinal Burkitt lymphoma whether they are immunomodulatory and/or initiating events.
The role of Pax5 in the pathogenesis and progression of IPSID lymphoma is worth investigating, too. Pax5 gene encoding the transcription factor BSAP is required for progression of B-lymphopoiesis beyond the pro-B stage. 69 Plasma cell differentiation involves repression of Pax5. For personal use only. on August 16, 2017 . by guest www.bloodjournal.org From
